Smith & Nephew plc logo
Smith & Nephew plc SNN
$ 34.32 0.94%

Annual report 2025
added 04-04-2026

report update icon

Smith & Nephew plc Gross Profit 2011-2026 | SNN

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Smith & Nephew plc

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
4.19 B 4.05 B 3.82 B 3.68 B 3.67 B 3.16 B 3.8 B 3.61 B 3.52 B 3.4 B 3.49 B 3.46 B 3.25 B 3.07 B 3.13 B

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.19 B 3.07 B 3.55 B

Gross Profit of other stocks in the Medical devices industry

Issuer Gross Profit Price % 24h Market Cap Country
Align Technology Align Technology
ALGN
2.8 B $ 184.65 2.2 % $ 13.8 B usaUSA
Avinger Avinger
AVGR
2 M - -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
198 M - - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
6.6 M - 1.37 % $ 20.5 M usaUSA
AxoGen AxoGen
AXGN
167 M $ 34.7 3.66 % $ 1.6 B usaUSA
BioSig Technologies BioSig Technologies
BSGM
229 K - 37.08 % $ 85.7 M usaUSA
Conformis Conformis
CFMS
23.2 M - - $ 16.4 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
67.9 M - - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
-3.14 M - -26.83 % $ 2.62 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
89.3 M $ 12.44 0.97 % $ 1.68 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
443 K - 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
584 K - -5.86 % $ 30.6 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
342 M $ 290.0 0.64 % $ 8.18 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
26.5 M $ 0.58 -0.6 % $ 36.1 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
1.65 B $ 40.53 3.79 % $ 6.04 K usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
26.6 M $ 3.33 0.15 % $ 125 M franceFrance
Boston Scientific Corporation Boston Scientific Corporation
BSX
13.9 B $ 63.5 0.51 % $ 94 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
42.4 M - - $ 475 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
173 M - 0.15 % $ 844 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
22.7 M $ 10.34 3.3 % $ 293 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
6.01 M - 14.99 % $ 929 K usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
500 K - -0.97 % $ 54.4 M usaUSA
Electromed Electromed
ELMD
50 M $ 24.95 - $ 211 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
168 M - -4.14 % $ 702 M usaUSA
Inogen Inogen
INGN
154 M $ 6.56 1.71 % $ 175 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
19.2 M $ 1.04 0.97 % $ 17.6 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
4.25 K - -1.98 % $ 98.3 M usaUSA
GBS GBS
GBS
1.25 M - -0.57 % $ 7.12 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
28.7 M - 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
43.7 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
1.99 M - - $ 111 M canadaCanada
Globus Medical Globus Medical
GMED
719 M $ 93.82 0.9 % $ 12.7 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
61 K $ 2.03 -0.19 % $ 1.23 M usaUSA
Butterfly Network Butterfly Network
BFLY
48.8 M $ 4.34 1.4 % $ 919 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
50.2 M - - $ 955 M usaUSA
BIOLASE BIOLASE
BIOL
16.7 M - -13.19 % $ 166 K usaUSA
LENSAR LENSAR
LNSR
14.1 M $ 5.98 1.01 % $ 71.5 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
173 M $ 17.04 0.56 % $ 400 M usaUSA
Delcath Systems Delcath Systems
DCTH
73.4 M $ 10.66 2.01 % $ 382 M usaUSA
Myomo Myomo
MYO
26.9 M $ 0.74 1.44 % $ 31 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
779 M $ 55.86 1.79 % $ 1.64 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
750 M $ 39.17 1.85 % $ 1.22 B usaUSA
LivaNova PLC LivaNova PLC
LIVN
940 M $ 65.23 1.01 % $ 3.56 B britainBritain
Integer Holdings Corporation Integer Holdings Corporation
ITGR
500 M $ 88.7 1.11 % $ 3.08 B usaUSA
FONAR Corporation FONAR Corporation
FONR
42.4 M $ 18.7 -0.05 % $ 123 M usaUSA
Invacare Corporation Invacare Corporation
IVC
48.3 M - - $ 24.7 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
4.73 B $ 78.25 0.17 % $ 45.8 B usaUSA